T-cell receptor specific for Ovalbumin peptide-MHC complex (OVA-specific TCR)

The T-cell receptor (TCR) specific for the Ovalbumin (OVA) peptide-MHC complex is a specialized heterodimeric protein complex on the surface of T lymphocytes that recognizes specific peptides derived from chicken ovalbumin presented by Major Histocompatibility Complex (MHC) molecules (Janeway et al., 2001). This receptor system is most famously represented by the OT-I and OT-II transgenic mouse models, which are engineered to express TCRs specific for the MHC class I-restricted SIINFEKL peptide and the MHC class II-restricted OVA 323-339 peptide, respectively (Hogquist et al., 1994; Barnden et al., 1998). The primary biological function of this TCR is to initiate an adaptive immune response upon encountering its cognate antigen, leading to T-cell activation, clonal expansion, and effector functions such as the lysis of antigen-bearing cells. In the pharmaceutical industry, these TCRs serve as gold-standard preclinical models for evaluating the safety and efficacy of T-cell-based therapies, including TCR-engineered T-cells (TCR-T) and vaccines (Robbins et al., 2011). By providing a predictable and measurable immune response, the OVA-specific TCR system allows for the detailed study of TCR-pMHC binding kinetics and the downstream signaling pathways that are critical for developing human immunotherapies.

Other names

OT-I T-cell receptorOT-II T-cell receptorSIINFEKL-specific T-cell receptorOvalbumin-specific T-cell receptorOVA-pMHC-specific TCR

The TCR specifically recognizes and binds to the OVA peptide-MHC complex, triggering the phosphorylation of CD3 ITAMs by Lck kinase and initiating a signaling cascade through ZAP-70 that leads to T-cell activation. Therapeutic strategies targeting this system, such as TCR-engineered T-cells, leverage this recognition to direct immune effector functions against specific cells, while anti-CD3 antibodies can non-specifically modulate the signaling of the TCR complex (Janeway et al., 2001; Hogquist et al., 1994).